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httpcense.Abstract Background: The link between OSAS, left ventricular dysfunction, and congestive heart
failure is less known, although OSAS is frequent in both systolic and diastolic heart failure patients.
Aim: To study left ventricular function in patients with obstructive sleep apnea syndrome and to
assess the correlation between the severity of OSA and the degree of ventricular dysfunction.
Subjects and methods: This study was conducted on 45 subjects (22 males and 23 females) in
Chest Department, Tanta University Hospitals, they were classiﬁed into two groups: Group A
included 15 apparently healthy subjects, by sleep study they were normal as apnea hypopnea index
(AHI) < 5/h and oxygen desaturation index (ODI) < 5/h. Group B included 30 patients with
obstructive sleep apnea diagnosed by sleep study (AHI > 5/h and ODI > 5/h).
Results: Eight (26.66%) out of the 30 OSAS patients (group B) were hypertensive and have left
ventricular dysfunction. The mean value of AHI was (2.53±1.06) and (24.6±14.35) in groups A
and B, respectively. The mean value of AHI was signiﬁcantly higher in group B than group A
(p=0.001). Signiﬁcant correlation was found between AHI, diastolic and systolic dysfunctions,
respectively (r= 0.324; p= 0.019 and r=0.288; p=0.049).
Conclusion: Obstructive sleep apnea syndrome may predispose in left ventricular diastolic
dysfunction, AHI is correlated with the degree of left ventricular diastolic dysfunction.
ª 2012 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
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Obstructive apnea occurs when there is complete cessation of
airﬂow forP10 s while obstructive hypopnea occurs when air-
ﬂow decreases, resulting in a fall in oxygen saturation or arou-
sal from sleep [1].
OSA is quantiﬁed on the basis of the apnea–hypopnea in-
dex (AHI), which refers to the number of apneas and hypop-
neas occurring per hour of sleep. OSA is presumed to beis. Production and hosting by Elsevier B.V.
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444 M.G. El-Kholly et al.signiﬁcant at an AHI P5 events per hour [2]. Longitudinal
studies have found an association of untreated OSA with inci-
dent or recurrent cardiovascular disease events [3,4].
There are a number of mechanisms by which OSA may lead
to the development and progression of heart failure. Hyperten-
sion, left ventricular diastolic dysfunction, and AF, all of
which have been linked to OSA, are important causes of heart
failure [2].
The link between OSAS, left ventricular dysfunction, and
congestive heart failure is less known, although OSAS is fre-
quent in both systolic and diastolic heart failure patients [5].
Proposed mechanisms that affect left ventricular performance
in patients with OSAS include several mechanical, neurohu-
moral, inﬂammatory, endothelial, and oxidative effects [6].
The aim of this work was to study left ventricular function
in patients with obstructive sleep apnea syndrome, to assess
whether there is any correlation between the severity of OSA
and the degree of ventricular dysfunction.Subjects and methods
This study was conducted on 45 subjects (22 males and 23
females) in Chest Department, Tanta University Hospitals
During the period from July 2010 to July 2011. They were
classiﬁed into two groups: Group A (control group) which
include 15 apparently healthy subjects, by sleep study they
were normal as apnea hypopnea index (AHI) <5/h and
oxygen desaturation index (ODI) <5/h. and group B (patients
group) which include 30 patients with obstructive sleep apnea
diagnosed by sleep study (AHI > 5/h and ODI > 5/h).
AHI: The number of obstructed apnea and hypopnea per
hours of sleep.
ODI: The number of 4% drops in oxygen saturation per
hours of sleep.
Patients having primary cardiac diseases (e.g. congenital
heart diseases, rheumatic heart disease and ischemic heart dis-
ease), known neuromuscular disease, renal failure, pulmonary
diseases and patients in childhood period were excluded from
the study.
Patients gave written informed consent to participate in the
study. All patients were subjected to history taking and full
clinical examination, body mass index: (which is deﬁned by
dividing the weight in kilogram by square of the height in
meters), Epworth sleepiness scale (ESS) and chest X ray
(P-A) view.Table 1 Statistical comparison as regards age, BMI, neck circumfer
two studied groups.
Group A
Age 51.73 ± 3.73
Body mass index (kg/m2) 26 ± 1.81
Neck circumference (inch) 14.86 ± 1.06
Systolic blood pressure (mmHg) 128 ± 12.07
Diastolic blood pressure (mmHg) 83.33 ± 11.12
Apnea hypopnea index (AHI) 2.53 ± 1.06
Oxygen desaturation index (ODI) 2.66 ± 1.04
* p< 0.05.
** p< 0.01.Echocardiography was preformed to evaluate systolic and
diastolic functions of left ventricle and exclusion of primary
cardiac diseases as ischemic heart disease, rheumatic heart
diseases and congenital heart diseases.
Systolic function was assessed by left ventricle ejection frac-
tion (LVEF) which is the difference between the end-diastolic
and end-systolic volumes divided by the end-diastolic volume;
left ventricular mass derived from measurement of interven-
tricular septum thickness (IVSD) in diastole, left ventricle
posterior wall thickness (PWD) in diastole and left ventricle
end diastolic dimension (EDD) and left ventricular mass index
(LVMI) was calculated by dividing the left ventricular mass by
height (g m1) [7].
The diastolic parameters were measured or calculated from
at least three consecutive beats: E wave (peak ﬂow velocity in
early diastole); A wave (peak ﬂow velocity at atrial contrac-
tion); and the E/A ratio. Normal pattern was deﬁned by an
E/A ratio >1; impaired relaxation was deﬁned by an E/A ratio
<1; a pseudonormal pattern by an E/A ratio ranging from 1 to
1.5 and reversal of the E/A ratio (to <1.0) by Valsalva maneu-
ver; and a restrictive pattern by an E/A ratio >1.5 [8].
All subjectswere subjected to sleep studyusing theRESMED
Apnea Link System. The subjects were analyzed for apnea
hypopnea index, oxygen desaturation index and respiratory
disturbance index (RDI) which deﬁned as the number of
obstructive apneas, hypopneas and respiratory effort related
arousals (RERAs) per hour. The patient was diagnosed as
having OSA when AHI > 5/h, ODI > 5/h and RDI > 5/h.
The severity of obstructive sleep apnea was classiﬁed into mild
(AHI 5–15); moderate (15–30) and severe (>30) events per
hour.
Statistical analysis
Statistical presentation and analysis of the present study was
conducted using the mean, standard deviation (t test), and
chi-square test by SPSS V.16.
Results
This study was performed on 45 subjects; 15 apparently
healthy subjects, they were 6 (40%) males and 9 (60%) females
with mean age 51.73 ± 3.73 (group A) and 30 patients with
obstructive sleep apnea diagnosed by sleep study, they were
15 (50%) males and 15 (50%) females with mean age
55.63 ± 10.39 years (group B). The OSA group was further
classiﬁed to 16 mild (AHI < 15), 10 moderate (AHI 15–30),ence, blood pressure, AHI and Oxygen desaturation index in the
Group B t test p value
55.63 ± 10.39 1.402 0.168
32.23 ± 3.34 6.707 0.001**
18.53 ± 1.65 7.793 0.001**
150.66 ± 15.74 4.893 0.002*
94.66 ± 10.74 3.297 0.025*
24.6 ± 14.35 21.32 0.001**
28.16 ± 15.39 16.52 0.001**
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Figure 1 Apnea hypopnea index (AHI) in the two studied
groups.
Table 2 Systolic and Diastolic dysfunction in the two studied
groups.
Group A Group B v2 p value
Systolic dysfunction 0/15 (0%) 5/30 (16.7%) 2.813 0.841
Diastolic dysfunction 2/15 (13.3%) 28/30 (93.3%) 28.800 0.001**
v2: Chi-square.
** p 6 0.001.
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Figure 2 The correlation between apnea hypopnea index (AHI)
and left ventricular diastolic dysfunction.
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Figure 3 The correlation between apnea hypopnea index (AHI)
and left ventricular systolic dysfunction.
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tients (group B) were hypertensive and have left ventricular
dysfunction. The mean value of AHI was (2.53 ± 1.06and
24.6 ± 14.35) in groups A and B, respectively. The mean value
of AHI was signiﬁcantly higher in group B than group A
(p< 0.01). (Table 1; Fig. 1). All other clinical characteristics
of studied groups were shown in (Table 1).
Table 2 shows the number of patients with systolic and dia-
stolic dysfunction in the two studied groups. In group A, there
were no patients presented with systolic dysfunction while in
group B, there were 5 (16.7%) patients presented with systolic
dysfunction. As regards diastolic dysfunction, there were only
2 (13.3%) patients in group A while most patients in group B(93.3%) had diastolic dysfunction. Signiﬁcant correlation was
found between AHI, diastolic and systolic dysfunctions,
respectively (r= 0.324, p= 0.019 and r= 0.288, p= 0.049)
(Figs. 2 and 3).
Table 3 shows left ventricle echocardiography measure-
ments in the two studied groups. All patients in group B were
presented with impaired relaxation which was deﬁned by an E/
A ratio <1.
Discussion
Cardiovascular complications are the most serious complica-
tions of patients with OSAS. These complications include
hypertension, coronary artery disease, cardiac failure, left/
right ventricular dysfunction, cardiac arrhythmia, and pul-
monary hypertension [9].
Almost half of heart failure patients have a preserved sys-
tolic function, i.e. a left ventricular (LV) ejection fraction
(LVEF) >45%. Diastolic anomalies appear to be common
in OSA, but the majority of studies in this area have been car-
ried out on small patient populations [10,11]. Obstructive sleep
apnea syndrome contributes to development of LVH, and as
severity of OSAS increases the incidence of LVH increases
(Lorell and Carabello., 2000) [12]. Left ventricular hypertro-
phy (LVH) often seems to be associated with this LV diastolic
dysfunction [12].
In the present study, 8 (26.66%) out of the 30 OSAS
patients (group B) were hypertensive and have left ventricular
dysfunction. The mean value of AHI was (2.53 ± 1.06) and
(24.6 ± 14.35) in groups A and B, respectively. The mean
value of AHI was signiﬁcantly higher in group B than group
A (p= 0.001).
In the study by Hedner et al. [13], LVH was seen more in 61
male patients with OSAS than in the control group. In this
study, 50% of the patients had hypertension, and when the
normotensive group was evaluated, LVH incidence in
normotensive patients with OSAS was found 15% higher than
normotensive control group.
OSAS may increase cardiac risk due to impairment of rela-
tion between myocardial oxygen demand and supply as a re-
Table 3 Left ventricle echocardiography measurements in the two studied groups.
Group A Group B p value
(Left ventricular diastolic dysfunction) E to A ratio 1.33 + 0.37 0.95 + 0.27 0.015*
E wave (m/s) 0.84 + 0.20 0.89 + 1.3 0.258
A wave (m/s) 1.10 + 2.13 1.07 + 1.58 0.247
(Left ventricular systolic dysfunction) EF (%) 69.1 + 2.2 67.6 + 3.7 0.869
* p< 0.05.
446 M.G. El-Kholly et al.sult of hypoxia, hypercapnia, and increased sympathetic acti-
vation occurring during apnea and oxygen desaturation asso-
ciated with apnea triggered by myocardial ischemia at night
[7,14].
In a study by Dursunoglu et al. [15], in which LV diastolic
functions were assessed in patients with OSAS, although
LVEF was conserved in patients with moderate–severe OSAS,
it was found that there were LV diastolic dysfunction and LV
global dysfunction.
Otto et al. [16] evaluated LV functions conserved obese pa-
tients with and without OSAS, and demonstrated that LV dia-
stolic function impaired in patients with OSAS.
In the present study, there was signiﬁcant left ventricular
diastolic dysfunction in patients with obstructive sleep apnea.
One study found echocardiographic evidence of left ventric-
ular diastolic dysfunction in 56% of newly diagnosed OSA pa-
tients but in only 20% of control subjects; diastolic
dysfunction improved with CPAP therapy [17].
Several studies have documented a high prevalence of OSA
in patients with diastolic [17] and systolic [18] and heart failure.Conclusion
Obstructive sleep apnea syndrome may predispose in left ven-
tricular diastolic dysfunction and AHI is correlated with the
degree of left ventricular diastolic dysfunction.References
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